Terms: = Breast cancer AND NRG1, ENSG00000157168, 3084, SMDF, NDF, HRGA, HRG1, HGL, GGF2, GGF, ARIA AND Prognosis
15 results:
1. Single-Nucleus Transcriptome Profiling of Locally Advanced Cervical Squamous Cell cancer Identifies Neural-Like Progenitor Program Associated with the Efficacy of Radiotherapy.
Zhang L; Ma J; Zhou D; Zhou J; Hu B; Ma X; Tang J; Bai Y; Chen H; Jing Y
Adv Sci (Weinh); 2023 Sep; 10(25):e2300348. PubMed ID: 37424047
[TBL] [Abstract] [Full Text] [Related]
2. [Ductal adenocarcinoma of the pancreas: subtypes and molecular pathology].
Schlitter AM; Konukiewitz B; Kasajima A; Reichert M; Klöppel G
Pathologe; 2021 Sep; 42(5):464-471. PubMed ID: 34402977
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive analysis of autophagy-related prognostic genes in breast cancer.
Lai J; Chen B; Mok H; Zhang G; Ren C; Liao N
J Cell Mol Med; 2020 Aug; 24(16):9145-9153. PubMed ID: 32618109
[TBL] [Abstract] [Full Text] [Related]
4. NRG-1 Stimulates Serum DJ-1 Increase in breast cancers.
Wang Y; Zhang Y; Lu Q; Wang Y; Sun X; Zhang S
Pathol Oncol Res; 2019 Jan; 25(1):71-79. PubMed ID: 28963699
[TBL] [Abstract] [Full Text] [Related]
5. Circulating neuregulin-1 and galectin-3 can be prognostic markers in breast cancer.
De Iuliis F; Salerno G; Taglieri L; Lanza R; Cardelli P; Scarpa S
Int J Biol Markers; 2017 Jul; 32(3):e333-e336. PubMed ID: 28430337
[TBL] [Abstract] [Full Text] [Related]
6. Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy.
Chen K; Yang D; Li X; Sun B; Song F; Cao W; Brat DJ; Gao Z; Li H; Liang H; Zhao Y; Zheng H; Li M; Buckner J; Patterson SD; Ye X; Reinhard C; Bhathena A; Joshi D; Mischel PS; Croce CM; Wang YM; Raghavakaimal S; Li H; Lu X; Pan Y; Chang H; Ba S; Luo L; Cavenee WK; Zhang W; Hao X
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1107-12. PubMed ID: 25583476
[TBL] [Abstract] [Full Text] [Related]
7. Identification of mTORC2 as a necessary component of HRG/ErbB2-dependent cellular transformation.
Lin MC; Rojas KS; Cerione RA; Wilson KF
Mol Cancer Res; 2014 Jun; 12(6):940-52. PubMed ID: 24615340
[TBL] [Abstract] [Full Text] [Related]
8. Mechanisms of cardiotoxicity associated with ErbB2 inhibitors.
Fedele C; Riccio G; Malara AE; D'Alessio G; De Lorenzo C
Breast Cancer Res Treat; 2012 Jul; 134(2):595-602. PubMed ID: 22674190
[TBL] [Abstract] [Full Text] [Related]
9. The cooperation between hMena overexpression and HER2 signalling in breast cancer.
Di Modugno F; Mottolese M; DeMonte L; Trono P; Balsamo M; Conidi A; Melucci E; Terrenato I; Belleudi F; Torrisi MR; Alessio M; Santoni A; Nisticò P
PLoS One; 2010 Dec; 5(12):e15852. PubMed ID: 21209853
[TBL] [Abstract] [Full Text] [Related]
10. ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis.
Révillion F; Lhotellier V; Hornez L; Bonneterre J; Peyrat JP
Ann Oncol; 2008 Jan; 19(1):73-80. PubMed ID: 17962208
[TBL] [Abstract] [Full Text] [Related]
11. nrg1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis.
Prentice LM; Shadeo A; Lestou VS; Miller MA; deLeeuw RJ; Makretsov N; Turbin D; Brown LA; Macpherson N; Yorida E; Cheang MC; Bentley J; Chia S; Nielsen TO; Gilks CB; Lam W; Huntsman DG
Oncogene; 2005 Nov; 24(49):7281-9. PubMed ID: 16027731
[TBL] [Abstract] [Full Text] [Related]
12. Essential roles of Her2/erbB2 in cardiac development and function.
Negro A; Brar BK; Lee KF
Recent Prog Horm Res; 2004; 59():1-12. PubMed ID: 14749494
[TBL] [Abstract] [Full Text] [Related]
13. Expression of PEA3/E1AF/ETV4, an Ets-related transcription factor, in breast tumors: positive links to MMP2, nrg1 and CGB expression.
Bièche I; Tozlu S; Girault I; Onody P; Driouch K; Vidaud M; Lidereau R
Carcinogenesis; 2004 Mar; 25(3):405-11. PubMed ID: 14633660
[TBL] [Abstract] [Full Text] [Related]
14. Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas.
Rachwal WJ; Bongiorno PF; Orringer MB; Whyte RI; Ethier SP; Beer DG
Br J Cancer; 1995 Jul; 72(1):56-64. PubMed ID: 7599067
[TBL] [Abstract] [Full Text] [Related]
15. Interaction between erbB-receptors and heregulin in breast cancer tumor progression and drug resistance.
Lupu R; Cardillo M; Harris L; Hijazi M; Rosenberg K
Semin Cancer Biol; 1995 Jun; 6(3):135-45. PubMed ID: 7495981
[TBL] [Abstract] [Full Text] [Related]
